In Reply
- PMID: 29578974
- DOI: 10.1097/AOG.0000000000002555
In Reply
Comment on
- 
  
  Placental Alpha Microglobulin-1 Compared With Fetal Fibronectin to Predict Preterm Delivery in Symptomatic Women.Obstet Gynecol. 2017 Dec;130(6):1183-1191. doi: 10.1097/AOG.0000000000002367. Obstet Gynecol. 2017. PMID: 29112664
- 
  
  Placental Alpha Microglobulin-1 Compared With Fetal Fibronectin to Predict Preterm Delivery in Symptomatic Women.Obstet Gynecol. 2018 Apr;131(4):743. doi: 10.1097/AOG.0000000000002554. Obstet Gynecol. 2018. PMID: 29578973 No abstract available.
References
- 
    - Nikolova T, Bayev O, Nikolova N, Di Renzo GC. Comparison of a novel test for placental alpha microglobulin-1 with fetal fibronectin and cervical length measurement for the prediction of imminent spontaneous preterm delivery in patients with threatened preterm labor. J Perinat Med 2015;43:395–402.
 
- 
    - Melchor JC, Navas H, Marcos M, Iza A, de Diego M, Rando D, et al. Retrospective cohort study of PAMG-1 and fetal fibronectin test performance in assessing spontaneous preterm birth risk in symptomatic women attending an emergency obstetrical unit. Ultrasound Obstet Gynecol 2017 [Epub ahead of print].
 
- 
    - Management of preterm labor. Practice bulletin No. 171. American College of Obstetricians and Gynecologists. Obstet Gynecol 2016;128:e155–64.
 
- 
    - Grobman WA, Welshman EE, Calhoun EA. Does fetal fibronectin use in the diagnosis of preterm labor affect physician behavior and health care costs? A randomized trial. Am J Obstet Gynecol 2004;191:235–40.
 
- 
    - Di Renzo GC, Cabero Roura L, Facchinetti F, Helmer H, Hubinont C, Jacobsson B, et al. Preterm labor and birth management: recommendations from the European Association of Perinatal Medicine. J Matern Fetal Neonatal Med 2017;30:2011–30.
 
Publication types
MeSH terms
Substances
LinkOut - more resources
- Full Text Sources
- Other Literature Sources
 
        